{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:21:58Z","timestamp":1792084918197,"version":"4.4.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 CA237726-01A1"],"award-info":[{"award-number":["K08 CA237726-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-CA093245"],"award-info":[{"award-number":["T32-CA093245"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006070","name":"Society of Surgical Oncology","doi-asserted-by":"publisher","award":["SSO YIA 2019"],"award-info":[{"award-number":["SSO YIA 2019"]}],"id":[{"id":"10.13039\/100006070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006512","name":"School of Medicine, Duke University","doi-asserted-by":"publisher","award":["OPSD"],"award-info":[{"award-number":["OPSD"]}],"id":[{"id":"10.13039\/100006512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00262-020-02698-2","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T20:03:31Z","timestamp":1597867411000},"page":"475-483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-9030","authenticated-orcid":false,"given":"Georgia M.","family":"Beasley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Therien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda K.","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Al-Rohil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angelica","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nellie E.","family":"Farrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuliu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premi","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Hanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita K.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"2698_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB, Group M (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599\u2013609 (2014PMC4058881)","journal-title":"N Engl J Med"},{"key":"2698_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","volume":"76","author":"SM Landow","year":"2017","unstructured":"Landow SM, Gjelsvik A, Weinstock MA (2017) Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992\u20132013. J Am Acad Dermatol 76:258\u2013263","journal-title":"J Am Acad Dermatol"},{"key":"2698_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/jid.2014.452","volume":"135","author":"DC Whiteman","year":"2015","unstructured":"Whiteman DC, Baade PD, Olsen CM (2015) More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland. Australia J Invest Dermatol 135:1190\u20131193","journal-title":"Australia J Invest Dermatol"},{"key":"2698_CR4","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1016\/S1470-2045(18)30596-5","volume":"19","author":"JJ Grob","year":"2018","unstructured":"Grob JJ, Garbe C, Ascierto P, Larkin J, Dummer R, Schadendorf D (2018) Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma? Lancet Oncol 19:e720\u2013e725","journal-title":"Lancet Oncol"},{"key":"2698_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2018.02.022","volume":"96","author":"D Verver","year":"2018","unstructured":"Verver D, van Klaveren D, van Akkooi ACJ, Rutkowski P, Powell B, Robert C, Testori A, van Leeuwen BL, van der Veldt AAM, Keilholz U, Eggermont AMM, Verhoef C, Grunhagen DJ (2018) Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations. Eur J Cancer 96:25\u201333","journal-title":"Eur J Cancer"},{"key":"2698_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF (2017) Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67:472\u2013492 (2017PMC5978683)","journal-title":"CA Cancer J Clin"},{"key":"2698_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/2326-6066.CIR-14-0167","volume":"3","author":"A Holtzhausen","year":"2015","unstructured":"Holtzhausen A, Zhao F, Evans KS, Tsutsui M, Orabona C, Tyler DS, Hanks BA (2015) Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy. Cancer Immunol Res 3:1082\u20131095 (2015PMC4927300)","journal-title":"Cancer Immunol Res"},{"key":"2698_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/978-1-4939-9773-2_25","volume":"2055","author":"JM Beechem","year":"2020","unstructured":"Beechem JM (2020) High-plex spatially resolved RNA and protein detection using digital spatial profiling: a technology designed for immuno-oncology biomarker discovery and translational research. Methods Mol Biol 2055:563\u2013583","journal-title":"Methods Mol Biol"},{"key":"2698_CR9","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1158\/1078-0432.CCR-19-0104","volume":"25","author":"MI Toki","year":"2019","unstructured":"Toki MI, Merritt CR, Wong PF, Smithy JW, Kluger HM, Syrigos KN, Ong GT, Warren SE, Beechem JM, Rimm DL (2019) High-plex predictive marker discovery for melanoma immunotherapy-treated patients using digital spatial profiling. Clin Cancer Res 25:5503\u20135512 (2019PMC6744974)","journal-title":"Clin Cancer Res"},{"key":"2698_CR10","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","volume":"24","author":"CU Blank","year":"2018","unstructured":"Blank CU, Rozeman EA, Fanchi LF, Sikorska K, van de Wiel B, Kvistborg P, Krijgsman O, van den Braber M, Philips D, Broeks A, van Thienen JV, Mallo HA, Adriaansz S, Ter Meulen S, Pronk LM, Grijpink-Ongering LG, Bruining A, Gittelman RM, Warren S, van Tinteren H, Peeper DS, Haanen J, van Akkooi ACJ, Schumacher TN (2018) Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat Med 24:1655\u20131661","journal-title":"Nat Med"},{"key":"2698_CR11","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","volume":"24","author":"RN Amaria","year":"2018","unstructured":"Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA (2018) Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 24:1649\u20131654","journal-title":"Nat Med"},{"key":"2698_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/CMR.0000000000000383","volume":"27","author":"AA Tarhini","year":"2017","unstructured":"Tarhini AA, Floros T, Lin HM, Lin Y, Rahman Z, Ashraf M, Vallabhaneni P, Sander C, Rao UNM, Panelli M, LaFramboise WA, Kirkwood JM (2017) A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma. Melanoma Res 27:429\u2013438 (2017PMC5657445)","journal-title":"Melanoma Res"},{"key":"2698_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/CMR.0000000000000396","volume":"27","author":"C Alessi","year":"2017","unstructured":"Alessi C, Scapulatempo Neto C, Viana CR, Vazquez VL (2017) PD-1\/PD-L1 and VEGF-A\/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival. Melanoma Res 27:565\u2013572","journal-title":"Melanoma Res"},{"key":"2698_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bjd.13100","volume":"171","author":"I Chevolet","year":"2014","unstructured":"Chevolet I, Speeckaert R, Haspeslagh M, Neyns B, Kruse V, Schreuer M, Van Gele M, Van Geel N, Brochez L (2014) Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control? Br J Dermatol 171:987\u2013995","journal-title":"Br J Dermatol"},{"key":"2698_CR15","doi-asserted-by":"publisher","first-page":"e0133363","DOI":"10.1371\/journal.pone.0133363","volume":"10","author":"M Messaoudene","year":"2015","unstructured":"Messaoudene M, Perier A, Fregni G, Neves E, Zitvogel L, Cremer I, Chanal J, Sastre-Garau X, Deschamps L, Marinho E, Larousserie F, Maubec E, Avril MF, Caignard A (2015) Characterization of the microenvironment in positive and negative sentinel lymph nodes from melanoma patients. PLoS ONE 10:e0133363 (2015PMC4517810)","journal-title":"PLoS ONE"},{"key":"2698_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/modpathol.2012.43","volume":"25","author":"MW Ma","year":"2012","unstructured":"Ma MW, Medicherla RC, Qian M, Vega-Saenz de Miera E, Friedman EB, Berman RS, Shapiro RL, Pavlick AC, Ott PA, Bhardwaj N, Shao Y, Osman I, Darvishian F (2012) Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Mod Pathol 25:1000\u20131010 (2012PMC3882943)","journal-title":"Mod Pathol"},{"key":"2698_CR17","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/0008-5472.CAN-03-2969","volume":"64","author":"M Movassagh","year":"2004","unstructured":"Movassagh M, Spatz A, Davoust J, Lebecque S, Romero P, Pittet M, Rimoldi D, Lienard D, Gugerli O, Ferradini L, Robert C, Avril MF, Zitvogel L, Angevin E (2004) Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res 64:2192\u20132198","journal-title":"Cancer Res"},{"key":"2698_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jid.2017.09.036","volume":"138","author":"F Rubel","year":"2018","unstructured":"Rubel F, Kern JS, Technau-Hafsi K, Uhrich S, Thoma K, Hacker G, von Bubnoff N, Meiss F, von Bubnoff D (2018) Indoleamine 2,3-dioxygenase expression in primary cutaneous melanoma correlates with breslow thickness and is of significant prognostic value for progression-free survival. J Invest Dermatol 138:679\u2013687","journal-title":"J Invest Dermatol"},{"key":"2698_CR19","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1126\/science.1073514","volume":"297","author":"DH Munn","year":"2002","unstructured":"Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, Slingluff CL Jr, Mellor AL (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297:1867\u20131870","journal-title":"Science"},{"key":"2698_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1158\/2326-6066.CIR-17-0249","volume":"6","author":"BL Horton","year":"2018","unstructured":"Horton BL, Williams JB, Cabanov A, Spranger S, Gajewski TF (2018) Intratumoral CD8(+) T-cell apoptosis is a major component of T-cell dysfunction and impedes antitumor immunity. Cancer Immunol Res 6:14\u201324 (2018PMC5754226)","journal-title":"Cancer Immunol Res"},{"key":"2698_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","volume":"20","author":"GV Long","year":"2019","unstructured":"Long GV, Dummer R, Hamid O, Gajewski TF, Caglevic C, Dalle S, Arance A, Carlino MS, Grob JJ, Kim TM, Demidov L, Robert C, Larkin J, Anderson JR, Maleski J, Jones M, Diede SJ, Mitchell TC (2019) Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study. Lancet Oncol 20:1083\u20131097","journal-title":"Lancet Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02698-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-020-02698-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02698-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T23:22:44Z","timestamp":1629328964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-020-02698-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2698"],"URL":"https:\/\/doi.org\/10.1007\/s00262-020-02698-2","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no relevant conflicts of interest to disclose related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}